DHL expands life science infrastructure in Mexico

With the launch of a specific sector strategy almost three years ago, the company has already invested another US$6 million in the site. The new unit strengthens DHL Supply Chain’s operational structure and solidifies its position in the life science & healthcare sector in Mexico – one of the ten largest markets in the world.

DHL Supply Chain has been developing the Pharmashare concept since 2007. The Pharmashare solution is a robust platform of information systems that manages both the warehouse systems and transportation processes and can be easily integrated with a client’s own systems. The platform enables DHL Supply Chain to provide the specialised warehousing and distribution services for Life Science & Healthcare companies for multiple goods, including medical devices and biotechnology products as well as non-prescription, generic and patented drugs. 

This latest warehouse addition increases the company’s capacity for this sector by more than 80%. Pharmashare can offer customers more than 54,000 m2 of space, including 31,000 m2 dedicated to product storage and shipping capacity. 

The new facility nearly quadruples DHL Supply Chain’s capacity to store goods in a temperature-controlled environment from an existing 3,070 m2 to more than 13,500 m2, an area where more than 51 million doses can be handled.